PHT International
PHT International is a privately held, US-headquartered CRDMO and chemical supplier founded in 1993, serving pharmaceutical, agrochemical, and specialty chemical companies with custom synthesis, process R&D, cGMP manufacturing in China, and global sourcing across 27+ countries.
- Company typePrivate
- Founded1993
- HeadquartersCharlotte, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What PHT International does
PHT International, Inc., founded in 1993 by Lihong Yu and headquartered in Charlotte, North Carolina, is a privately held contract research, development, and manufacturing organization (CRDMO) and chemical supplier serving pharmaceutical, agrochemical, and specialty chemical companies across more than 27 countries and 163 destinations. It operates two divisions: a Traditional Business Unit providing chemical sourcing, logistics, QA/regulatory compliance, and custom intermediate manufacturing; and a Pharma Business Unit delivering CRO, process R&D, and cGMP CDMO services from an FDA-inspected Shangyu, China manufacturing facility and a process R&D site in Nantong, China, with sales offices in Switzerland and Japan.
The technical platform spans capabilities from milligrams to multi-tons, centered on flow chemistry, DoE-driven process development, batch and flow hydrogenation, asymmetric/chiral synthesis, solid-form development, and an ICH-Q7-aligned quality system, supplemented by an exclusive green-chemistry collaboration with UC Santa Barbara's Professor Bruce Lipshutz laboratory. Manufacturing is anchored in wholly owned subsidiaries in China, with strategic equity exposure to Insight FineChem for agrochemical CMO capacity.
PHT monetizes through quote-based, project-priced CRDMO contracts (custom synthesis, process development, scale-up, cGMP manufacture of pharmaceutical intermediates, regulatory starting materials, and APIs) and through transactional chemical sourcing and supply of complex intermediates and specialty chemicals. Go-to-market is enterprise sales-led with dedicated account managers, supported by inside sales and active participation in SOCMA, DCAT, and CPHI events globally. Quality and reliability signals include OTIF above 98%, zero safety incidents over the last 10 years, 11+ million kg shipped annually, 750+ orders per year, and certifications including cGMP, CTPAT, EcoVadis Silver, SBTi commitment, SOCMA, DCAT, WBENC, and NMSDC.
PHT International firmographics
Firmographics- Name
- PHT International
- Legal name
- PHT International, Inc.
- Website
- https://phtinternational.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PHT International is a privately held, US-headquartered CRDMO and chemical supplier founded in 1993, serving pharmaceutical, agrochemical, and specialty chemical companies with custom synthesis, process R&D, cGMP manufacturing in China, and global sourcing across 27+ countries.
- Ownership category
- akta.pro rank
PHT International industry classification
Industry- Product category
- Contract Chemical Manufacturing
- NAICS
- Chemical Manufacturing (325), Pharmaceutical Preparation Manufacturing (325412), Scientific Research and Development Services (5417)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731), Wholesale-Chemicals & Allied Products (5160)
- akta.pro primary industry
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
Keywords
Where PHT International is headquartered
LocationHeadquarters
- HQ city
- Charlotte
- HQ country
- United States
- HQ region
- North America
Offices9 records
Markets served
PHT International business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- CRDMO Services: Contract Research, Development, and Manufacturing Organization services including custom synthesis, process R&D, analytical development, scale-up, and cGMP manufacturing of pharmaceutical intermediates, regulatory starting materials, and APIs. Revenue generated through project-based contracts spanning from early discovery through commercial production.
- Chemical Sourcing and Supply: Strategic sourcing and supply of complex intermediates, custom intermediates, and specialty chemicals to pharmaceutical, agrochemical, and specialty chemical industries. Includes logistics coordination, customs facilitation, and supply chain management services.
- Manufacturing of Custom Intermediates: Custom manufacturing of RSMs, advanced intermediates, and specialty chemicals. Revenue derived from production contracts with pricing based on volume and complexity.
- Process Development: Development of custom synthetic routes, process optimization, and technology transfer services for pharmaceutical and chemical customers.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
PHT International product offering
Product offeringCore offering
PHT International is a CRDMO (Contract Research, Development, and Manufacturing Organization) and chemical supplier serving the pharmaceutical, agrochemical, and specialty chemical industries. The company provides CRO services, process R&D, CDMO services, strategic chemical sourcing, and integrated logistics support. Founded in 1993, PHT delivers end-to-end chemical development from initial discovery research through commercial-scale manufacturing under cGMP/ICH-Q7 quality systems.
Product overview
PHT International is a full-service CRDMO (Contract Research, Development, and Manufacturing Organization) and chemical supplier serving the pharmaceutical, agrochemical, and specialty chemical industries. The company operates two integrated divisions: the Traditional Business Unit providing Chemical Supplier services (Strategic Sourcing, Logistics, QA & Regulatory Compliance, Process Development & Manufacturing) and the Pharma Business Unit offering CRO, Process R&D, and CDMO services from state-of-the-art facilities in China. The platform spans capabilities from custom synthesis and process development through cGMP manufacturing, supported by advanced technologies including Flow Chemistry, DoE Principles, and Quality/Data Integrity systems.
Differentiator
Problem solved
Functional benefit
Products and services
- CRDMO Services
Quantifiable outcome
- On-time, in-full delivery rate >98% in 2025
- +4 more outcomes
Companies that use PHT International
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
PHT International technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
PHT International partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, major and innovation.
- Basilea Pharmaceutica ChinacoreAcquired Basilea Pharmaceutica China operations to boost CRO services and enhance CDMO capabilities for innovative customers. This acquisition established PHT's process R&D site in Nantong, expanding the CRDMO platform.
- Insight FineChemmajorEquity investment in Insight FineChem to enhance PHT's fine chemical manufacturing capacity and CMO business for crop protection customers. Strategic investment to expand manufacturing capabilities for agricultural intermediates and AIs.
- UCSB Professor Bruce Lipshutz Green Chemistry LabinnovationExclusive collaboration with UC Santa Barbara sponsoring a post-doctorate researcher in Professor Bruce Lipshutz's Green Chemistry Lab. Represents PHT's commitment to innovation and sustainable chemistry practices.
- Sancus Arc BiochemcoreAcquired FDA-inspected, cGMP manufacturing facility to establish PHT's own manufacturing capabilities for APIs and regulated intermediates. This acquisition formed the foundation of PHT's Shangyu CDMO facility in China.
- Strategic Manufacturing Partners and Joint VenturescorePHT established partnerships and joint venture arrangements with manufacturers in China for production of custom intermediates and regulated market products. In-house development with scale-up at partner sites, supplying APIs and AIs from partners and JV facilities. These relationships form the foundation of PHT's manufacturing capabilities.
- Global Manufacturers NetworkcoreLong-term relationships established with global manufacturers across Asia, South America, North America, and Europe to ensure stable supply chains and flexible manufacturing solutions for customers. PHT's in-house procurement team with 15+ years experience manages these partnerships.
Scale indicators12 records
Recent moves9 records
Expansion highlights6 records
PHT International competitors and assessment
Company assessmentDirect peers
- Asymchem Laboratories: China-based small molecule CRDMO offering integrated CRO, process R&D, and cGMP API manufacturing from milligrams to commercial scale. Closest comparable to PHT by business model, geographic footprint, and customer base (global pharma and biotech), but materially larger and publicly listed.
- WuXi STA (WuXi AppTec subsidiary): Global leader in small molecule CDMO with integrated discovery, development, and commercial manufacturing capabilities including flow chemistry and continuous manufacturing. Direct overlap with PHT's CRDMO platform serving pharma and agrochemical customers globally.
- PharmaBlock Sciences: China-headquartered CDMO/CRO focused on small molecule intermediates, building blocks, and APIs with cGMP manufacturing capabilities. Direct competitor to PHT in custom synthesis and process R&D for global pharma and specialty chemical customers.
- Sai Life Sciences: India-based CRDMO offering discovery chemistry, process R&D, and cGMP API manufacturing services to global pharma. Comparable to PHT in integrated service offering and target customer segments, with similar focus on small molecule lifecycle management.
- Cambrex (Symeres): Specialty small molecule CDMO providing API development, manufacturing, and analytical services from early development through commercial supply. Now part of Symeres, with global facilities serving similar pharma customer base as PHT.
- Hovione: Portugal-headquartered CDMO specializing in API development and manufacturing with strong flow chemistry and particle engineering capabilities. Direct peer to PHT in small molecule CDMO with comparable technology focus and pharma customer base.
- Jubilant Pharmova: India-based integrated pharma company offering CDMO services, APIs, and formulations with strong process R&D and cGMP manufacturing capabilities. Comparable to PHT in serving global pharma with cost-efficient Asia-based manufacturing.
Broad incumbents
- Lonza: Global CDMO leader offering small molecule, biologics, and cell therapy services at scale. PHT competes in overlapping small molecule and API manufacturing segments, but Lonza operates much larger commercial scale and broader therapeutic modalities.
- Catalent: Major global CDMO with broad capabilities across small molecule, biologics, and softgel manufacturing. Overlaps with PHT in API and drug product CDMO services, but operates at materially larger scale with much broader service portfolio.
Emerging players
- Aurigene Pharmaceutical Services: India-headquartered CRO/CDMO offering discovery chemistry, process development, and custom manufacturing for pharma and biotech. Comparable emerging CRDMO with similar integrated service model, though earlier-stage commercial scale than PHT.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
PHT International social profiles
Digital presencePHT International compliance and trust
Trust signalCompliance8 records
PHT International financial estimates
Financial estimateRevenue estimate
Valuation estimate
PHT International leadership team
Management profileNumber of profiles
Profiles1 record
PHT International subsidiaries and ownership
Company hierarchySubsidiaries9 records
PHT International funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PHT International M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PHT International
What does PHT International do?
PHT International is a CRDMO (Contract Research, Development, and Manufacturing Organization) and chemical supplier serving the pharmaceutical, agrochemical, and specialty chemical industries. The company provides CRO services, process R&D, CDMO services, strategic chemical sourcing, and integrated logistics support. Founded in 1993, PHT delivers end-to-end chemical development from initial discovery research through commercial-scale manufacturing under cGMP/ICH-Q7 quality systems.
Is PHT International a public or private company?
PHT International is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PHT International founded?
PHT International was founded in 1993. It employs 11 to 50 people.
Where is PHT International based?
PHT International is headquartered in Charlotte, United States, in the North America region.
How does PHT International make money?
Four revenue lines are on record. CRDMO Services are the primary driver. The others are chemical Sourcing and Supply, manufacturing of Custom Intermediates and process Development.
Who are PHT International's main competitors?
Direct peers on record are Asymchem Laboratories, WuXi STA (WuXi AppTec subsidiary), PharmaBlock Sciences, Sai Life Sciences, Cambrex (Symeres), Hovione and Jubilant Pharmova. Broad incumbents are Lonza and Catalent. Aurigene Pharmaceutical Services is listed as an emerging player.
Does PHT International have an API?
No public API is recorded for PHT International.
What industry is PHT International in?
PHT International's product category is Contract Chemical Manufacturing. Its primary akta.pro industry code is HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 325 and its SIC code is 2834.